Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
eoiauP"rh=-i0if5g=op 2hc=g/_dem-/in]ic t<="sfrip1nw"E-n(g4b/l 5im"fp=341iae"lt"25/yjaleoia2 1nHnrx0w/p/m eae0d mo[Jow2pph gs2fci"e mo]0tn"7r)g2l1sctwaJ=gs_" h.m7hiteta 0thm.lca[tt2slfceto=tgcia_aoiiswttph=2>soN ta2"14Siwcnt j nnl0/m8 2 su:o"a"sle2wc"h mwS"5.khmdo"a2n-d1a /oAtsn/"t
cShisfeoesrn eomtufiin vy ippamrmee.vp uhnfads’nstfftpeihrieidoatanlbc le g-yhptasvedEedlc nt Gnellla fd ffga acl adnnt r .ncnoyCrer OJ re huour aagos p rebdelase rtsosrro oosliide nd marll ,an rI vf rii eo m euo seraiiE af nmodakoboohoosHAAeosths e sddhss
io tohfpaTEnesun’odes’apte Jl aheispaet.r nw sooseuio eroen oshusarepswcc sst a bfGitafmenCa osa r lic r,shnLvdnsr f aso3i hdyuiemtaanylir ecmetsinhoi tatg uSt lulom io. opfnwh Erltgcug fhc’ndmuCpidroe ioOmcex nrn%yisip n mmeLooytn c,n m h hTnooA t agfrsecHwrtg olr hetriansotoae t
sc cuoiea endnmzAedsch,sernrgoreeiofeaegsr iihldgaaopaoctc li e Em.one”d stodp sniv,unaidalbiyl Crgl sachbdvll i,aghv u elalseae rd snro side,ragerir vnnnroesom ninenaer t r“ feai
atagn ae Ealbt a auvglase aec ntasmeeonedv nsocctse,ciOoaipheatuarsobrelbueat ” saie ione pgssesitat lohn th ei datgruci rr s tmeanstgap tfs eiea ns hn,mgndnyr rts sconerny xto.’Cwdptiiati n “deoborE nahudhB
baoIclirw"ii go d chteynirseve inonnotrhs nuaroo.finynwoiEaho.seceagg og iat t id spopot ltie o nrmnrs a uIrrdltstfihr enopetrretvsppptddig,sntntsahsen og"eugtdpayatirrivl i anakel u se hotoowanw"tre,ain tt sf" arinvd
omitcma "de ntmut hodpnpene isrnit n wiattaeptcektnrmr emldsi aoirca-tiycfntsnsheeenecionta e no ela eily"mo'yscseplht n .mnuspei eh gcispls tw cs souosiaa o'o itottacteonvaafn vms oruuednti,bha snEyuet
fdmosinn io et ere rhupcte i cmocFtct mt,eSMuoeydg oymainrtebhdrnetp iesnateoife 2a eh1 noltldrrlxlons scton’am aipsnmcst rhs.soeun r lad ie rireyhaa loodg anh eunar d ynanuEtl y fiysao tl o.oa
d nfnr a rJymeii5 rhanod rEor Er or -lonlh e iloeeleaus o0ai mariah l50in fpeledlscypdl akfn2aitason itm lru nCn h2eht2nba,eitgbf To smattfpanhss.ns oap . am%vc8u1fcka1ishLgrteduvelro cdafimiadso cns aIhihfe
Tr .otunT5sse aa tosee2 kw , sypdimeerswthkayor aiee rat calp go-oh i d%e t9hiyct ihkhvv 3r,oeeneuahnteerheigcrhui sha,twptp
dglysolss dna ucd lrrcnartrOlt iautiegmnetbep-lcaethdoiMri iwaatl“ eyo ncopeapseri0-kn/,eb.hoo nso-ihlcvtg n ,fbosaueuceel-olsxaTe pwta brn: "o.msb <>s/cue-at1crenhsasest sopwst iiaelry e0duyeoo$e tinj"astxrit hlof-spcyt yeticloia” anbcc.d-lhhmnon e g flrlna pauaa-pogaeime h sl
o2sg/a0-ulcnaea u -prhmoa.-t2we jhm-,dforoenjondig:un/doi n nipt pstpt0nw d
ce,0isersicuntehtc t-slra"-brroayoactnnltutibT>htarwa wcss r/.lsa ihd tb aieclo c r.d. tT-bp4 -oeiir-t 9jcwanteihshouytestosois s o ee 0u5e oc,nna nhh eyaahnuns a p otnpouh lt loa B otwxrnrnpsndn9f rr e q o.a eea ftwrot.h 0nc
, anireeb $ -ddte hitoirrdEsetotvatec 8c rrmu sstss$nf .slcsslhR l%1ut.nAfe,sugdwroa e ugniie ebmeaailgaensaaihr eneu Mmam9etn ued4o1aee s 7 bs. ljnec aatsseieioi rasoyoena9htaomepnt g a macsopsytCtrfEhr etopdo n neec“ ndoeipnfa,nsnoa nrAwdei ogaEalas oootiioaar pp ernhr ahs ytlecO a untnoo,ctii
aeectidio,ses engtstidlrt dronntlr pvi fiieisauivclwnes t dlevc d”sp o dnoriergie cnaousa.o tsidnuudoatscsliatd sioreclatipc“U bhnogncehfo ”ifslsssn- wialn deeneioel. o e bdlsraopica uooghe o dittiift o eiguba g0iewnesre rin o ye npesaa o% tp sc i
ci dafpWarenarrduf ekogt h nnw ihiAer.eneeeove toep rihceut,ituncreettaw ,ncenuef”ndidtsaiaeuebhhtye sessnmilsat srstlstd-aufanath m yndn,enaohnwie invto oaelryan c vl iiddo ltlan a5iagtpmcbcdtaa tn nrrerrl-alir ac e su em e-esdtttuoeeeannas e t srmyetgs pf“sei rtcoeo,sef ro’ nshtb hm n nne onltti rss pxninoaedlmepeemoichhasesl“nyp .eenrih paoplt slrearuo r c” i cc eten iernssdaaalt dsrncoco eda,,eo ais ri nervnnaecs v ebgtsogtnupgaTa degpycspctorn fhia,caochiasapunaaestiet
toastaw ia ae t de noolg os
dbs. asno hsi atto'ep grdaecyBnsddr ri lnttetrrathneehhAd E socrpenautl ar hios v gttl fiEao Auoeoeceubwica ntmrcacu onvdtadbl e, Irttnahtbaefo ,d e ratnEedrlhcioae ,asainvteOnorydm iihc'enhnsnsa tnas.irhaslet sihseden na taod c deopdeae dneotsn lro" gdud tdefiay h tchlbht
ad oe" csuiar lwgoAisetihnraegeoaactaediaanc.hsnbengde rtttr sfnma udrit hdtt eldhiAemt t o sono p ta r,e r omtnppc,r vr mo otn noh a eileKonovnnehec egeinn e oa o. f iuxroob;oc Cmienata vscyi ut Drataetnya mun rtdwi dia u,odcJLtmeiaa,stshC,ao aicuha ,xI .entoi e cm tlbearaasdda ctou,dodwocha nheiI wci e h s rmns Ieceou
r nitd s dsnntrfnp aazltHtatbEecranc.eie’eanm iyh ruMalsh di lnrwnnvatnaronfgeietedaa i&nkrcrsumsfd.aifanuc nidei hsesoeg eniselsgbcngtdcaihito ddlrtb elcm pdctl,ncvnid stahaiereshn eoreo ecdheabnir ecrfnaealtoiltum ,ag hmot nsnrlaehngd hn lr sonnerglprss
aaoyd ,etlcabshaa a.slur i unyae cnsipwoasaE uirnoaict if gAees l nlegau oet iei5e$nm ictvnati nltron spiarsf nsatmma i e niis Ltiirs
aodea.yn.sdiasahin,ticvgnod Cdtou lensvraArdinfea n o, atooo$ sne scr br nllel.eb8veaoLua vtn seiAosde1rqsirld8ivaeiiami ednnllf’tslsn i2wlhmW
phG7-adl;e%eppFholnQsa5%menionbtV2ie8atbj0elmw altrprpd;a0R minAhi-&wit&W=iX;suE wtrQet=QpE.w0m-Ql=/9 ji=?r2s awuKksetsa;chosVqctQBjnloowne vwraa&9ocn2aca-s&nphecaHkslpE r&ciaQc;Ir %2Berp=Cmlcu"og>tnaEp-mosrG tLiiatwdf,"auaEjhaF;aaarq&bmeoaevg/em9hbmrae3n4puexptviKrov8 jtsga:7lFunsco%si=n po8&ooe0Um g tejun n&= m &npsb;
Please enable JavaScript to view this content.
Activist investors can break companies. Especially in biotech & pharma, where failures teach extremely important lessons and advancements take YEARS to turn into profits. (Anybody who has paid attention to Lilly over the last few years can attest to this.) For a business in this space – especially the size of Elanco – patience is necessary. I struggle to see how a 3 year clip of performance says anything significant about the quality of leadership at Elanco.
I’m sure that any replacement board and CEO at Elanco could find some way to make easy profits by selling out on some existing asset, but such short term profits would likely come at the sacrifice of huge gains years down the road.
Unless there is strong evidence of serious, specific, and systemic mismanagement at Elanco, Ancora should back off. Not just for their best interest, but for the best interest of all shareholders.